Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

US stocks to open lower as oil price rally runs out of steam

US blue-chips are set for a dull opening, especially Estée Lauder, which disappointed with a trading update

A dull end to the week is in store, with the main benchmarks tipped to open lower.

The S&P 500 is trading at around 2,180 on spread betting platforms, some seven points down from last night’s close.

The Dow Jones average is being quoted at 18,542, down 56 points from last night’s close.

European markets are providing no encouragement with the Footsie in London and the Dax in Frankfurt both drifting lower.

The oil price has found reverse gear again with West Texas sweet light crude down 0.4% at US$48.05 a barrel, although the European benchmark, Brent crude for October delivery, has kept its head above the $50 mark at US$50.54 a barrel, down 35 cents.

There is not much point looking to the gold bullion market for profits, either, as the price of the December futures contract for the yellow metal was off 0.9% at US$1,344.70 an ounce.

On the corporate news front Estée Lauder Companies Inc (NYSE:EL) disappointed the market with its outlook for the new business year.

The cosmetics company was off 2.8% in pre-market trading.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK